"From ERα66 to ERα36: a generic method for validating a prognosis ..."

Clémence Chamard-Jovenin et al. (2015)

> Home

Details and statistics

DOI: 10.1186/S12918-015-0178-7

access: open

type: Journal Article

metadata version: 2020-10-26

- view
  - electronic edition via DOI (open access)
  authority control:
- export record
  dblp key:
  - journals/bmcsb/Chamard-Jovenin15
- ask others
- share record
  persistent URL:
  - https://dblp.org/rec/journals/bmcsb/Chamard-Jovenin15
Clémence Chamard-Jovenin, Alain Jung, Amand Chesnel, Joseph Abecassis, Stéphane Flament, Sonia Ledrappier, Christine Macabre, Taha Boukhobza, Hélène Dumond:
From ERα66 to ERα36: a generic method for validating a prognosis marker of breast tumor progression. BMC Syst. Biol. 9: 28 (2015)

manage site settings

To protect your privacy, all features that rely on external API calls from your browser are turned off by default. You need to opt-in for them to become active. All settings here will be stored as cookies with your web browser. For more information see our F.A.Q.